1、CommercialisingI P f rom research Annual Report&Fi nanci al StatementsYear ended 30 June 2018FRONTIER IPGROUP PLCSTRATEGIC REPORT5Key Points6Chairmans Statement9Strategy10 Business Model12 Chief Executive OfficersStatement13 Key Performance I ndicators14 Operational Review15 Portfolio Review21 Finan
2、cial Review20 Key Risks and Challengesaffecting the GroupOUR GOVERNANCE24 Board of Directors28 Committees of the Board30 Audit Committee Report31 Corporate Governance37 Advisers38 Directors Report39 Statement of DirectorsResponsibilities40 I ndependent Auditors ReportOUR FINANCIALS44 Group Statement
3、s44 Consolidated Statement of Comprehensive I ncome45 Consolidated Statement of Financial Position46 Company Statement of Financial Position47 Consolidated and CompanyStatements of Changes in Equity48 Consolidated and CompanyStatements of Cash Flows49 Accounting Policies53 Notes to the Financial Sta
4、tementsCOMPANY INFORMATION68 Five Year RecordRegistered number 06262177ContentsCover:clockwi se from top left Dr Alasdair Bremner(L)and Professor David Binns,Alusid Professor Mathew Upton,Amprologix Associate Professor Michael Jarvis,The Vaccine Group Dr Martin Stoelen,Fieldwork RoboticsProfessor El
5、vira Fortunato(L)and Professor Rodrigo Martins,NTPE 1“This year saw further good progress,reflecting thehard work put in by the team and our partners.Weagain materially increased the value of our portfolio,added three new spin outs and built on the strongrelationships we enjoy with our partner insti
6、tutions,academics and industry.I n line with building astrong platform for future growth,we saw adecrease in profit before tax,primarily due to higherpeople and premises costs.I ncreased investment in these areas has allowed us to grow our level of activity and accelerate value creation in theportfo